Close Menu

This article has been updated from a previous version to include financial details about Qiagen's acquisition of Formulatrix's digital PCR assets.

NEW YORK (GenomeWeb) – Qiagen yesterday announced several new product initiatives and acquisitions to coincide with the first day of the JP Morgan Healthcare Conference, as it continues to stake its claim as one of the most diversified life science research tools and molecular diagnostics companies.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.